Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas' cardiomyopathy

Acta Tropica

Volumn 120, Issue 3, 2011, Pages 219-223

  Miguel, Carlos E ^a   Bortoluzzi, Talita B ^a   Otaviano, Ana Paula ^a   Cardinalli Neto, Augusto ^a   Faria da Rocha, Bianca ^a   Ferrari, Samira J ^a   Bestetti, Reinaldo B ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

American; Anemia; Cardiomyopathy; Chagas' disease; Heart Failure; Trypanosomiasis

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; INOTROPIC AGENT; SODIUM; SPIRONOLACTONE;

ANEMIA; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; HEMOGLOBIN; MORTALITY;

ADULT; ANEMIA; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SURVIVAL; SYSTOLIC HEART FAILURE;

ADULT; AGED; ANEMIA; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; FEMALE; HEART FAILURE, SYSTOLIC; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80054868306     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.08.012     Document Type: Article

References (24)

1. Adams K.F., Patterson J.H., Oren R.M., Mehra M.R., O'Connor C.M., Piña H.L., Miller A.B., Chiong J.R., Dunlap S.H., Cotts D.G., Felker G.M., Schocken D.D., Schwartz T.A., Ghali J.K. Prospective assessment of the occurrence of anemia in patients with heart failure: results from the study of anemia in a Heart Failure Population (Stamina HFP) Registry. Am. Heart J. 2009, 157:926-932.
2. Anand I.S., Kuskowiski M.A., Rector T.S., Florea V.G., Glazer R.D., Chiang Y.T., Aknay N., Maggioni A.P., Opasich, Latini R., Cohn J.N. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure. Circulation 2005, 112:1121-1127.
3. Anonymous, 2009. A human rights-based approach to neglected tropical diseases. (accessed 20.08.09). http://apps.who.int/tdr/svc/publication/tdr.research%20publications/human%20rights.
4. Bestetti R.B., Sales-Neto V.N., Pinto L.Z., Soares E.G., Muccillo G., Oliveira J.S. Effects of long term metoprolol administration on the electrocardiogram of rats infected with T. cruzi. Cardiovasc. Res. 1990, 24:521-527.
5. Bestetti R.B. Role of parasites in the pathogenesis of Chagas' cardiomyopathy. Lancet 1996, 347:913-914.
6. Bestetti R.B., Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int. J. Cardiol. 1997, 60:187-193.
7. Bestetti R.B., Theodoropoulos T.A.D., Cardinalli-Neto A., Cury .P.M. Treatment of chronic systolic heart failure secondary to Chagas' heart disease in the current era of heart failure therapy. Am. Heart J. 2008, 156:422-430.
8. Ferreira S.M.A., Guimarães G.V., Cruz F.D., Issa V.S., Bacal F., Souza G.E.C., Chizzola P.R., Mangini S., Bocchi E.A. Anemia and renal failure as predictors of risk in a mainly non-ischemic heart failure population. Int. J. Cardiol. 2010, 141:198-200.
9. Freitas H.F.G., Chizzola P.R., Paes A.T., Lima A.C.P., Mansur A.J. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int. J. Cardiol. 2005, 102:239-247.
10. Ghali J.K. Anemia and heart failure. Curr. Opin. Cardiol. 2009, 24:172-178.
11. Groenveld H.F., Januzzi J.L., Damman K., Wijngaarden J., Hillege H.L., Veldhuisen D.J., van der Meer P. Anemia and mortality in heart failure patients. J. Am. Coll. Cardiol. 2008, 52:818-827.
12. Guerri-Guttenberg R.A., Grana D.R., Ambrosio G., Milei J. Chagas cardiomyopathy: Europe is not spared!. Eur. Heart J. 2008, 21:2587-2591.
13. Issa V.S., Amaral A.F., Cruz F.D., Ferreira S.M., Guimarães G.V., Chizzola P.R., Souza G.E., Bacal F., Bocchi E.A. Beta-Blocker therapy and mortality of patients with Chagas' cardiomyopathy - a subanalysis of the REMADHE prospective trial. Circ. Heart Fail. 2010, 3:82-88.
14. Komajda M., Anker S.D., Charlesworth A., Okonko D., Metra M., di Lenarda A. The impact of new onset anemia on morbidity and mortality in chronic heart failure: results from COMET. Eur. Heart J. 2006, 27:1440-1446.
15. Milei J., Guerri-Guttenberg R.A., Grana D.R., Storino R. Prognostic impact of Chagas disease in the United States. Am. Heart J. 2009, 57:22-29.
16. Mocelin A.O., Issa V.S., Bacal F., Guimarães G.V., Cunha E., Bocchi E.A. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. 2005, 7:869-873.
17. Nanas J.N., Matsouka C., Karageorgopoulos D., Leonti A., Tsolakis E., Drakos S.G., Tsagalou E.P., Maroulidis, Alexopoulos G.P.E.G., Kanakakis J.E., Anastasiou-Nana M.I. Etiology of anemia in patients with advanced heart failure. J. Am. Coll. Cardiol. 2006, 48:2485-2489.
18. Parra A.V., Rodrigues V., Cancella S., Cordeiro J.A., Bestetti R.B. Impact of socioeconomic status on outcome of a Brazilian heart transplant recipients cohort. Int. J. Cardiol. 2008, 125:142-143.
19. Rossi M.A., Ramos S.G., Bestetti R.B. Chagas' heart disease: clinical-pathological correlation. Front. Biosci. 2003, 8:e94-e109.
20. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 2007, 102(Suppl. 1):75-85.
21. Tang W.H., Tong W., Jain A., Francis G.S., Harris M., Young J.B. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J. Am. Coll. Cardiol. 2008, 51:569-576.
22. Willenheimer R., van Heldhuisen D.J., Silke B., Erdmann E., Follath F., Krum H., Ponikowiski P., Skene A., van de Ven L., Verkenne P., Lechat P. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril as compared with the opposite sequence. Circulation 2005, 112:2426-2435.
23. Young J.B., Abrahan W.T., Albert N.M., Stough W.G., Gheorghiade M., Greenberg B.H., O'Connor C.M., She L., Sun J.L., Yancy C.W., Fonarow G.C. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (Insight from the OPTIMIZE-HF Registry). Am. J. Cardiol. 2008, 101:223-230.
24. WHO Technical Report Series 905, 2002. Control of Chagas disease. World Health Organization, Geneva, Switzerland. Report no WHO_TRS_905.pdf.